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Abstract
Background: Gene set enrichment testing has helped bridge the gap from an individual gene to a systems
biology interpretation of microarray data. Although gene sets are defined a priori based on biological knowledge,
current methods for gene set enrichment testing treat all genes equal. It is well-known that some genes, such as
those responsible for housekeeping functions, appear in many pathways, whereas other genes are more
specialized and play a unique role in a single pathway. Drawing inspiration from the field of information retrieval,
we have developed and present here an approach to incorporate gene appearance frequency (in KEGG pathways)
into two current methods, Gene Set Enrichment Analysis (GSEA) and logistic regression-based LRpath framework,
to generate more reproducible and biologically meaningful results.
Results: Two breast cancer microarray datasets were analyzed to identify gene sets differentially expressed
between histological grade 1 and 3 breast cancer. The correlation of Normalized Enrichment Scores (NES) between
gene sets, generated by the original GSEA and GSEA with the appearance frequency of genes incorporated (GSEA-
AF), was compared. GSEA-AF resulted in higher correlation between experiments and more overlapping top gene
sets. Several cancer related gene sets achieved higher NES in GSEA-AF as well. The same datasets were also
analyzed by LRpath and LRpath with the appearance frequency of genes incorporated (LRpath-AF). Two well-
studied lung cancer datasets were also analyzed in the same manner to demonstrate the validity of the method,
and similar results were obtained.
Conclusions: We introduce an alternative way to integrate KEGG PATHWAY information into gene set enrichment
testing. The performance of GSEA and LRpath can be enhanced with the integration of appearance frequency of
genes. We conclude that, generally, gene set analysis methods with the integration of information from KEGG
PATHWAY performs better both statistically and biologically.
Background
Traditional microarray data analysis mainly focuses on
identifying individual genes whose expression levels are
associated with a certain phenotype [1]. However, to
generate a biologically meaningful hypothesis based on a
handful of genes is often challenging. To overcome the
limitations of individual gene level analysis, gene set
enrichment analysis [2] was introduced and is now
widely used as a strategy for gene expression analysis
over pathway knowledge. Gene set enrichment analysis
using “cutoff-free” expression data integrated with prior
biology knowledge generates consistent and biologically
relevant results. Several gene set analysis strategies have
been developed, such as GSEA [3], SAM-GS [4], LRpath
[5], GAGE [6], Random Set Scoring [7], etc. Based on
prior biological knowledge, such as chromosomal loca-
tion, Gene Ontology term assignment, publicly available
databases, conserved regulatory motif in the promoter
region, etc., each of these approaches defines sets of
genes that are considered to be involved in the same
underlying biological process. Typically, all genes in a
gene set are treated equally in subsequent analysis.
However, genes involved in multiple pathways may not
be as distinctive as genes specific to one pathway, and
therefore may be less informative from a biological per-
spective. For example, specific receptors interacting with
a ligand are more characteristic of a ligand-receptor
pathway than signal trasduction kinases, which could
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any medium, provided the original work is properly cited.play different roles in several pathways. From a gene set
analysis point of view, if most of the significant differen-
tially expressed genes in a particular gene set function
in multiple pathways, the corresponding gene set might
be enriched, but this result could also be a false positive
result. Placing excessive concentration on differentially
expressed genes with multiple roles could easily disguise
the discovery of genes with less significant differential
expression but higher specificity.
A similar problem has been studied extensively in the
field of Information Retrieval. Given a set of search
terms entered by the user, the system task is to find the
most relevant documents. In evaluating the relevance of
a document, the occurrence of the search terms in the
document is considered. If all search terms are treated
equally, it has been observed that commonly occurring
terms, which are actually less useful in identifying rele-
vant documents, swamp out the more specific search
terms that occur less frequently. To address this pro-
blem, it is standard practice to weight search terms by
their inverse document frequency (IDF) defined for term
× as the reciprocal of (the logarithm of) the number of
documents (in the repository) in which the search term
occurs.
Among the many different ways to define gene sets,
public databases are considered to be among the most
informative, since these pathways are manually curated
by experts in the area and supported by experimental
evidence. KEGG (Kyoto Encyclopedia of Genes and
Genomes) PATHWAY [8] is a collection of manually
drawn pathway maps representing molecular interaction
and reaction networks for Metabolism, Genetic Informa-
tion Processing, Environmental Information Processing,
Cellular Processes, and Human Diseases. As part of a
systems biology approach, KEGG can be viewed as a vir-
tual biological system containing various types of infor-
mation essential for the recreation of an organism. In
short, KEGG PATHWAY integrates all the molecular
interaction knowledge from wet lab experiments into
one database.
If we took all the pathways in KEGG as a virtual bio-
logical system, the appearance frequency of each gene
could be a reliable indicator for the specificity of each
gene to a pathway. Low appearance frequency genes are
more specific to a pathway; if these genes show signifi-
cant differential expression, then there is a good chance
the corresponding pathway is activated. High appearance
frequency genes function in multiple pathways; the sig-
nificant differential expression of these genes could
affect a number of pathways, and they are therefore less
likely to lead to the identification of any particular path-
way. It is also possible to observe several high appear-
ance frequency genes cause the enrichment of truly
affected pathway, while other pathways containing the
same set of high frequency genes are indirectly enriched
solely due to the overlapping genes. These indirectly
enriched pathways interfere with the identification of
the true positive pathway.
Motivated by these ideas, we propose a novel
approach to characterize genes using information pro-
vided by KEGG. We propose a weighting strategy based
on the appearance frequency of each gene in KEGG
PATHWAY maps and incorporate it into gene set ana-
lysis methods. We applied the weights to the analysis of
two independent breast cancer datasets and two inde-
pendent lung cancer datasets. The results with our
weights were compared with results using the original
GSEA, and showed an increase in consistency between
datasets. The weighting method was also incorporated
into a novel logistic regression based gene set analysis
method, LRpath. The combination of LRpath and our
weighting strategy provided more reproducible and bio-
logically meaningful results than using the original
LRpath alone. Detailed information can be found at
http://eecs.umich.edu/db/think/.
Results and discussion
The distribution of appearance frequency of genes in
KEGG PATHWAY
W eb e g i nw i t ha na n a l y s i so ft h eK E G GP A T H W A Y
database to confirm our assumptions regarding the vary-
ing appearance frequency of genes and to explore the
biological basis for the observed variance. Figure 1
shows the distribution of appearance frequency of genes
within KEGG PATHWAY. Half of the genes appear
only once in a specific pathway. These genes are evenly
distributed among all KEGG PATHWAY gene sets,
without significant enrichment in any particular gene
set. A decreasing proportion of genes have an increasing
frequency of appearance. Less than two percent of
KEGG PATHWAY genes appear more than sixteen
times. This figure reflects the underlying biology of sig-
naling pathways and the property of gene occurrence
within them. If we take a closer look at the group of
genes with high appearance frequency (> = 16 counts),
the analysis result generated by the functional annota-
tion tool DAVID Bioinformatics resources [9] shows
that the most enriched molecular function GO term in
this group is phosphotransferase activity, also known as
kinase activity. A kinase is a type of enzyme that func-
tions in phosphorylation, which is used to modify the
activity of proteins, and subsequently transmit signals.
MAP Kinases are known to regulate various cellular
activities, especially those involved in signal transduc-
tion. An extraordinarily diverse group of cellular func-
tions, including cell growth, proliferation, differentiation,
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related to the ability of PI 3-kinases to activate Akt
kinases. Mitogen-activated protein (MAP) kinase, Phos-
phoinositide 3-kinase, AKT family kinase and their rela-
tional proteins are all among genes with top appearance
frequency.
Figure 2 shows genes involved in the mTOR signaling
pathway (pathway map taken from KEGG PATHWAY,
http://www.genome.jp/kegg/pathway/hsa/hsa04150.html)
and their corresponding appearance frequency in KEGG
PATHWAY. Current research reveals that the mTOR
pathway integrates the input from multiple upstream
stimuli, including environment energy stress, insulin,
growth factors and mitogen [10]. In the lower part of
the map, CAB39 (MO25 as shown in the map) enhances
the formation of STK11/STRAD complexes. This com-
plex is important for maintaining energy homeostasis
and appears only in the mTOR signaling pathway. On
the left side are Insulin and Insulin-like growth factor 1,
which are involved in several cancer related pathways.
The extracellular signals are transducted via the PI3K
and MAPK signaling pathway. Both of them are high
appearance frequency signal transduction kinases. The
mTOR complex is composed of mTOR, regulatory asso-
ciated protein of mTOR (Raptor) and G-protein b-like
protein (GbL). Although mTOR appears in other path-
ways, Raptor and GbL exclusively appear in the mTOR
signaling pathway. The direct downstream targets of the
mTOR complex are S6K1 and 4EBP1. Activated S6K1
can in turn initiate protein synthesis and translational
machinery. Activated 4EBP1 releases translation initia-
tion factor eIF4E to perform its function. Since S6K1
and 4EBP1 are always under the control of mTOR, they
have about the same appearance frequency as mTOR.
The indirect target of mTOR complex, ATG1, only
appears in the autophagy signaling pathway.
If we have a list of differentially expressed genes, and
most of the top genes are signal trasduction kinases,
such as MAPK, PI3K and AKT, we can’tb es u r e
whether the whole pathway is activated, since these
genes are not specific to the mTOR signaling pathway.
If S6K1 and 4EBP1 show significant changes, then there
is a good chance that mTOR is also activated. If mTOR
pathway specific protein Raptor and GbL are among the
top genes, alone with the environmental sensing STK11/
STRAD complex, then we can confidently conclude that
the mTOR signaling pathway is related to the pheno-
type. Most other pathways in KEGG follow a similar
pattern. The above example illustrates that when we
interpret microarray results in terms of affected path-
ways, if we could put higher weight on pathway specific
genes while putting less weight on genes with multiple
roles, then, with the integration of this new information,
the updated ranked list of significantly involved genes
could become more biologically meaningful.
Application of GSEA-AF
GSEA [3] is currently a widely used approach to gene
set enrichment testing. It uses a weighted version of the
Kolmogorov-Smirnov statistic to measure the degree of
Figure 1 The distribution of appearance frequency of genes in KEGG PATHWAY database. The number under the × axis indicates the
appearance frequency of each gene in KEGG PATHWAY. The y axis shows the proportion of genes with indicated appearance frequency out of
all KEGG PATHWAY genes. The total number of genes at each appearance count is indicated.
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integrate the appearance frequency of genes in KEGG
PATHWAY into GSEA.
In GSEA, genes are first ranked by signal to noise ratio.
A “running sum” statistic is calculated for each gene set,
based on the ranks of members in the set, relative to
those of non-members. An enrichment score (ES) is
defined to be the maximum of the running sum across
all genes, which corresponds to a weighted Kolomo-
gorov-Smirnov statistic. The weight places more impor-
tance on the top and bottom of the ranked list. When a
gene set contains a large number of highly ranked genes,
a high ES is achieved. A normalized enrichment score
(NES) is calculated for each gene set based on the size of
the set. NES is also used as the ranking metric to show
the final result of GSEA. For each gene set, a permuta-
tion-based false discovery rate (FDR) on NES is calcu-
lated and used to identify the significance of enrichment
across experiments. The FDR is adjusted for gene set size
and multiple hypothesis testing. To represent biologically
relevant correlation with the phenotype, the magnitude
of the increment can be weighted according to each
gene’s correlation with the phenotype. The equation for
the calculation of ES for a gene set S is given below, in
terms of two running sums, Phit and Pmiss, both com-
puted up to rank i in the ranked list of genes:
Phit(S,i)=

gj∈S
j≤i
 rj
 p
NR
,w h e r e NR =

gj∈S

rj


p
, Pmiss(S,i)=

gj / ∈S
j≤i
1
(N − NH)
where rj is the correlation of gene expression of gene
gj with the phenotype of interest, N is the total number
of genes in the data set, and NH is the number of genes
in one gene set.
The ES is the maximum deviation from zero of Phit-
Pmiss. In the original implementation of GSEA, the run-
ning-sum statistics used equal weights at every step (expo-
nent p = 0), which yielded high scores for sets clustered
near the middle of the ranked list [3]. Subramanian et al
addressed this issue by weighting the steps according to
each gene’s correlation with a phenotype, which corre-
sponded to take p = 1. The exponent p can be adjusted to
control the magnitude of each step. When p = 0, ES(S)
reduces to the standard Kolmogorov-Smirnov statistic,
Figure 2 Appearance frequencies of genes in the mTOR signaling pathway. The appearance frequency of each gene in the mTOR
signaling pathway is listed adjacent to the corresponding node in the map. Red color represents high appearance. Blue color represents low
appearance. Notice that kinase genes (AKT) tend to have higher frequency compare with mTOR pathway specific genes (Raptor and Gbl).
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their correlation with phenotype normalized by the sum
correlation over all genes in the set. We adjusted the value
of the exponent p according to the appearance frequency
of each gene. Since the correlation rj is 0[1], genes with
high appearance frequency should receive an exponent p
greater than 1 to reduce the magnitude of its effects. On
the other hand, genes with low appearance frequency
should receive an exponent p smaller than 1 to increase its
effect. In this way, if there is a large fraction of pathway
specific genes in a certain gene set ranked near the top or
bottom of the list, the corresponding gene set will have a
greater ES compared with the original GSEA. The appro-
priate value of p is determined based on a classical infor-
mation retrieval term weighting method as described in
the methods. In the following sections, we call the new
model with the integration of appearance frequency into
GSEA as GSEA-AF.
To demonstrate the validity of the new weighting
method, we also devised two additional variants of GSEA
as “controls": one based on a random appearance fre-
quency, and another on inverse frequency. For the for-
mer, the genes are randomized while the proportion of
genes with each appearance frequency is kept comparable
to the original distribution. RF (Random Frequency) is
used to indicate the resulting method. As another con-
trol, we generated an inverse appearance frequency, as
described in the methods, for each gene in KEGG path-
ways and indicate this method as IW (Inverse Weight).
We applied all four techniques, GSEA, GSEA-AF,
GSEA-RF, and GSEA-IW, on two independent breast
cancer datasets, which were originally analyzed and
compared in Sartor, et al [5]. For the first dataset,
human breast carcinoma samples were extracted from
patients with positive estrogen receptor (ER), among
which 29 samples are histological grade 1 and 12 sam-
ples are histological grade 3. In the second study, sam-
ples were taken from patients with similar condition,
where 39 samples are identified as histological tumor
grade 1 and 28 samples are histological tumor grade 3.
Both datasets were downloaded from NCBI Gene
Expression Omnibus public repository. Genes differen-
tially expressed between histological grade 1 and 3 sam-
ples were analyzed for enrichment of KEGG pathways.
As a standard to evaluate a method’s performance, if
there is high consistency between results obtained from
the two independent yet biologically similar datasets,
then the method is more reliable. Since NES is the rank-
ing metric in GSEA, concordance is measured by the
pearson correlation coefficient using the resulting NES
values for each dataset as input. Figure 3a shows the
consistency between the two datasets as measured by
GSEA, GSEA-AF, GSEA-RF and GSEA-IW. GSEA-AF
gave the highest consistency among the methods. The
consistency decreased with the application of random
frequency and inverse weight. Figure 3b examines the
number of overlapping KEGG pathways in the top
ranked list of GSEA and GSEA-AF, considering only the
KEGG pathways with FDR < = 0.05. GSEA-AF identified
more overlapping KEGG pathways than GSEA. Examin-
ing the overlapping gene sets with FDR < = 0.05 in the
ranked list generated by GSEA and GSEA-AF (Table 1),
we see that there are more overlapping gene sets discov-
ered by GSEA-AF. More specifically, one more breast
cancer related gene set was identified by GSEA-AF. In
addition to cell cycle, which has already been associated
Figure 3 Comparison of GSEA based methods on breast cancer datasets. a. The Pearson correlation between datasets was calculated based
on the Normalized Enrichment Score (NES) of each KEGG PATHWAY gene set generated by the original GSEA or with the integration of gene
appearance frequency (AF), random frequency (RF), inverse weight (IW). Error bars show the standard error of the mean. b. Ranked list of KEGG
Pathways was generated for each method and each dataset separately. The number of overlapping KEGG Pathways was calculated between
datasets for each method for increasing length of ranked list. Only pathways with FDR < = 0.05 are considered.
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reported that depressed expression levels of oxidative
phosphorylation were observed in human breast cancer
cells [12]. We also checked the improvement of analysis
results in each dataset separately. Table 2 lists the NES
and q-value of several cancer related gene sets generated
by GSEA and GSEA-AF from the Miller et al study [13].
Most of the top gene sets received higher NES in
GSEA-AF. Several metabolism pathways and non-cancer
related pathways, such as Huntington’s disease and type
II diabetes mellitus, were moved out of the top of the
ranked list.
Application of LRpath-AF
Several gene set analysis strategies have been proposed
in the literature in addition to GSEA. Following the
same logic, the appearance frequency of genes in KEGG
PATHWAY can be applied to these strategies as well.
As an example, we modified the logistic regression-
based method, LRpath, to integrate this information.
The basic concept of LRpath is that if the odds of a
gene belonging to a pre-defined gene set increases as
the significance of differential expression increases, then
this gene set is enriched. In the original LRpath, each
gene is assigned a statistical significance in terms of its
P-value using a test for differential expression chosen by
the user. For each gene set, genes within the gene set
are defined as 1, while all other genes are 0. If π is the
proportion of genes belonging to the gene set at a speci-
fied significance level, then π/(1-π)a r et h e
corresponding odds that a gene with significance × is a
member of this particular gene set. Logistic regression is
used to model the log-odds of a gene belonging to the
specific gene set as a linear function of the statistical
significance -log(P-value). Whether a gene set is
enriched or depleted with deferentially expressed genes
is tested using the slope parameter in the logistic regres-
sion equation.
The P-values of differential expression for genes, gen-
erated by the standard t-test, were transformed to -log
(P-value)s and used as input for LRpath. In addition to
the significance of each gene, these values could also
contain information about appearance frequencies. We
integrated this information into the LRpath input as
described in the methods section.
The same breast cancer datasets were used to com-
pare the results of LRpath and LRpath-AF. Again the
degree of correlation in significance of KEGG PATH-
WAYs between the two datasets was taken as the stan-
dard to measure the performance of the method. As
shown in Figure 4a, results from LRpath-AF had higher
correlation than LRpath. When random appearance fre-
quency was used as input, there was no increase in cor-
relation. The correlation of LRpath-IW was not
significantly different than the correlation given by
LRpath, and was significantly lower than the correlation
given by LRpath-AF. Among all the methods we have
tested, LRpath generally performed better than GSEA.
LRpath-AF has the highest correlation. Figure 4b exam-
ines the number of overlapping KEGG pathways in the
top ranked list of LRpath and LRpath-AF, considering
only the enriched KEGG pathways (odds ratio > 1).
LRpath-AF identified more overlapping KEGG pathways
than LRpath. In addition to cell cycle and Proteasome
gene sets, which were identified by GSEA, a well-known
cancer related pathway, p53 signaling pathway, was dis-
covered as significant by LRpath-AF.
Comparing results from two studies of lung cancer
To further demonstrate the advantage of applying
appearance frequency of genes in gene set analysis, we
applied the same methods as above on two lung cancer
datasets, which have been analyzed by the original
GSEA method [3] and several other methods [6]. These
two datasets were generated independently by research
groups in Boston (62 samples) and Michigan (86 sam-
ples). Gene expression profiles in tumor samples from
patients with lung adenocarcinomas were obtained by
microarray. Based on clinical outcomes, the samples
were classified as having a “good” or “poor” outcome.
The patients with “good” clinical outcome were defined
as control, and differentially expressed genes associated
with “poor” outcome were identified. The individual
gene level analysis did not show any significant overlap
Table 1 Comparison of overlapping gene sets generated
by GSEA and GSEA-AF
Methods Overlap
Gene Sets
(FDR < 0.05)
Cancer
Related
Gene Sets
Name of Gene Sets
GSEA 7 3 Proteasome, Cell cycle,
Biosynthesis of steroids
GSEA-AF 9 4 Proteasome, Cell cycle,
Biosynthesis of steroids,
Oxidative phosphorylation
The ranked list generated by GSEA was ranked by NES. Only gene sets with q-
value less than 0.05 were considered.
Table 2 Comparison of individual gene sets generated by
GSEA and GSEA-AF
KEGG Pathway GSEA GSEA-AF
NES FDR(q-value) NES FDR(q-value)
Cell-cycle 2.038 0.0 1.943 0.0
Oxidative phosphorylation 1.974 0.0 2.014 0.0
Biosynthesis of steroids 1.77 0.03 1.812 0.02
Proteasome 1.544 0.05 1.707 0.04
P53 signaling Pathway 1.62 0.08 1.667 0.05
Pancreatic cancer 1.385 0.21 1.612 0.08
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detect more similarities and provided biological insights
through the identification of overlapping gene sets.
We compared the results of GSEA, GSEA-AF, GSEA-
RF, GSEA-IW, LRpath, LRpath-AF, LRpath-RF, and
LRpath-IW on these two datasets following the same
procedure as described above. As shown in Figure 5,
incorporating the appearance frequency of genes reveals
greater consistency between datasets. The correlations
of results are not affected by the integration of random
frequency. Among all methods, LRpath-AF resulted in
the highest correlation. The top ranked list generated by
LRpath-AF also shows more overlapping enriched gene
sets. Compared with the original LRpath, more cancer
disease gene sets are among the top using LRpath-AF,
including Non-small cell lung cancer. Several other can-
cer related signaling pathways and cellular processes are
significantly enriched as well, such as VEGF signaling
pathway, which is essential for the sustained angiogen-
esis in tumor growth [14].
Conclusions
Current statistical approaches are able to identify signifi-
cantly differentially expressed genes individually, but
knowing a list of significant genes is not sufficient to
make conclusions about the underlying biological pro-
cesses. Development of gene set analysis methods has
made the interpretation of microarray results at a sys-
tems biology level much easier. Instead of focusing on
individual genes, researchers can focus on gene sets,
w h i c hg i v em o r er e p r o d u c i b l ea n di n t e r p r e t a b l er e s u l t s .
Without requiring an arbitrary cutoff of significance, the
changes of all genes in an experiment can be considered.
Although the construction of gene sets is based on
biological knowledge, most current methods fail to take
full advantage of the available resources. Recently, there
have been efforts to bring more pathway-specific infor-
mation into the analysis of microarray data. Draghici et
al [15] reported a novel impact analysis method, in
which they tried to capture a number of additional fac-
tors that may affect the analysis results. Additional
information from KEGG PATHWAY, such as the posi-
tion of the differentially expressed genes in the path-
ways, the topology of the pathway that describes gene
relations and the types of interactions among them,
were taken into account in the analysis of differentially
expressed genes. The latest publication from the same
Figure 4 Comparison of LRpath based methods on breast cancer datasets. a. The pearson correlation between datasets was calculated
based on the significance of each KEGG PATHWAY gene set generated by the original LRpath or with the integration of gene appearance
frequency (AF), random frequency (RF), or inverse weight (IW). Error bars show the standard error of the mean. b. Ranked list of KEGG Pathways
was generated for each method and each dataset separately. The number of overlapping KEGG Pathways was calculated between datasets for
each method for increasing length of ranked list. Only the enriched KEGG pathways are considered (odds ratio > 1).
Figure 5 Correlation between lung cancer datasets across
methods. The pearson correlation between datasets was calculated
based on results generated by GSEA, GSEA-AF, GSEA-RF, GSEA-IW,
LRpath, LRpath-AF, LRpath-RF, LRpath-IW. Error bars show the
standard error of the mean.
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false positive rate for short lists of differentially
expressed genes and to make the model less sensitive to
noise in the expression data [16]. The impact analysis is
a good combination of a traditional statistical approach
with biology knowledge. However there is no discussion
of appearance frequency.
In this paper, we provided the motivation for and pro-
posed a strategy to integrate more biologically meaning-
ful information into gene set analysis. First, the
appearance frequency of each gene in KEGG pathways
was determined. Further analysis showed that the
appearance frequency of genes has potential relations to
the property of the gene. Greater appearance frequency
indicates less specificity to a particular gene set, and
t h e r e f o r em o r el i k e l yt oc r e a t eaf a l s ep o s i t i v er e s u l t .
Fewer appearances indicate the function of the gene is
important to a particular biological process. The signifi-
cant changes of low appearance genes are more likely to
be highly related to the perturbation of the correspond-
ing pathway. We adopted a classical approach in infor-
mation retrieval to determine the weight to be used for
adjustment of the methods. The performance of each
method was assessed using two independent breast can-
cer data sets and two independent lung cancer datasets.
The observed concordance of the results was improved
with the integration of appearance frequency of genes.
Compared with original GSEA and LRpath, the updated
versions give more reproducible and biologically mean-
ingful results. The successful integration of the appear-
ance frequency of genes into GSEA and LRpath also
suggests the potential to apply this information to other
gene set analysis methods.
Methods
Determination of the exponent value p in GSEA-AF
To determine the appropriate value for the exponent p,w e
adopt a classical information retrieval term weighting
method [17]. The importance of a term in a given docu-
ment can be estimated by multiplying the raw term fre-
quency (TF) of the term in a document by the term’s
inverse document frequency (IDF) weight. The importance
increases proportionally to the number of times a word
appears in the document but is offset by the frequency of
the word in a collection. This method was easily trans-
formed for our purpose. Each pathway map is composed
of a group of genes, which is the analog of a document
and the words in it. Since most genes only appear once in
a given pathway map, the term frequency doesn’t provide
further useful information in our case. There are 195
KEGG pathway maps in KEGG database, which could be
viewed as a collection of documents. The inverse term fre-
quency is a measure of general importance of the term.
IDF is obtained by dividing the number of all documents
by the number of documents containing the term, and
then taking the logarithm. In our case, the number of
documents containing the term is the appearance fre-
quency of genes across all KEGG PATHWAY gene sets.
In order to make genes with low appearance having a
higher weight, the exponent p needed to be adjusted to
less than 1. We used the average of IDF of all genes as a
criterion to determine the level of appearance frequency.
The exponent p is determined as below:
p =
1
n
n 
i=1
idfi

idfi
where idfi defined as idfi =l o g ( 1 9 5 / fi), fi is gene
appearance frequency, i = 1,..., n.
This resulted in the exponent p ranging from 0.73 to 2.
When the appearance frequency is 4, the exponent p
approximately equals 1. Low appearance frequency genes get
an exponent p less than 1, while high appearance genes get
an exponent p greater than 1, which leads to a smaller
weight. In additional validations, using more (or less) extreme
ranges of the exponent p did not continue to improve results,
as assessed by correlation between the breast cancer datasets
and lung cancer datasets (additional file 1).
Generation of inverse appearance frequency
The purpose of using inverse appearance frequency and
random appearance frequency is to make sure the posi-
tive effect of appearance frequency on GSEA and
LRpath is specific, rather than an artifact of the method
in general. In GSEA-RF, appearance frequencies were
assigned to each gene randomly, while the proportions
of genes with each appearance frequency were kept
comparable to the original distribution. In GSEA-IW
and LRpath-IW, higher weights were put on genes that
are involved in multiple pathways.
Our method for running the IW tests preserves the
true distribution of numbers of pathways to which
genes belong. We generated an inverse appearance fre-
quency for each gene in KEGG pathways based on their
actual appearance frequency. For example if one gene
has appearance frequency of 1, a random appearance
frequency between 20-30 is taken as its inverse appear-
ance frequency. If one gene has appearance frequency
greater than 20, the inverse appearance frequency of
this gene is set to 1. This way the true distribution of
appearance frequency of all genes in KEGG pathways
are approximately preserved, and the adjustment on the
exponent p in IW tests is also closer to the scale used
for GSEA-AF and LRpath-AF. Ten sets of inverse
appearance frequency were generated and used as fi in
equation for determine exponent p in IW tests. The
mean and the standard error of the mean of the correla-
tions in IW tests were calculated.
Ma et al. BMC Bioinformatics 2011, 12:81
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Appearance frequency can be applied to different signifi-
cance measures in LRpath. In the original LRpath, the
statistical significance of each gene is represented by its
P-value. We applied the exponent p on the -log(P-
value), since LRpath performs logistic regression on this
P-value transformation and it preserves the information
about the relative significance levels in the P-values.
After the -log(P-value) transformation, genes with lower
appearance frequency should have greater -log(P-value)
to enhance their significance, while genes with higher
appearance frequency should move down in significance,
corresponding to a lower -log(P-value). We again
adopted the idea of TF-IDF described above to deter-
mine the parameter used for adjusting the -log(P-
values). Finally, the appearance frequency adjusted -log
(P-values) were passed into LRpath for analysis.
Additional material
Additional file 1: Supplementary_material_AF_paper. This file
describes the test results on using extreme range of exponent p.
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